(KAI) Kadant - Overview
Stock: Fluid-Handling, Doctoring, Cleaning, Conveying, Granules
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.43% |
| Yield on Cost 5y | 0.94% |
| Yield CAGR 5y | 7.86% |
| Payout Consistency | 100.0% |
| Payout Ratio | 19.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 38.7% |
| Relative Tail Risk | -9.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.08 |
| Alpha | -26.46 |
| Character TTM | |
|---|---|
| Beta | 1.338 |
| Beta Downside | 1.300 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.23% |
| CAGR/Max DD | 0.49 |
Description: KAI Kadant January 10, 2026
Kadant Inc. (NYSE:KAI) designs and manufactures engineered systems for fluid handling, industrial processing, and material handling, serving global markets in packaging, tissue, wood products, and alternative fuels.
The Flow Control segment offers rotary joints, turbulator bars, expansion joints, and a suite of filtration and cleaning consumables; the Industrial Processing segment supplies debarkers, stranders, chippers, knife systems, and automation equipment for pulp-based and recycling operations; the Material Handling segment provides conveyors, vibratory equipment, balers, and biodegradable absorbent granules for agricultural and spill-control applications.
Products are sold through a mix of direct sales, independent agents, and distributors. Kadant, originally Thermo Fibertek, rebranded in July 2001 and has been headquartered in Westford, Massachusetts since its 1991 incorporation.
Recent financial snapshots (FY 2023) show revenue around $1.2 billion with an operating margin near 12% and a backlog of roughly $300 million, indicating steady demand despite cyclical pressures in the pulp-and-paper sector. Key economic drivers include rising e-commerce packaging volumes, sustainability mandates that boost demand for recyclable materials, and the gradual shift toward bio-based fuels that fuels equipment sales in the Industrial Processing segment. The broader industrial machinery space remains sensitive to capital-expenditure cycles, with a 5-year average cap-ex growth rate of ~3% in Kadant’s core end-markets.
For a deeper, data-driven look at Kadant’s valuation metrics and scenario analysis, you might find ValueRay’s platform worth a quick glance.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 102.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 0.29 > 1.0 |
| NWC/Revenue: 30.02% < 20% (prev 25.56%; Δ 4.46% < -1%) |
| CFO/TA 0.11 > 3% & CFO 162.5m > Net Income 102.0m |
| Net Debt (131.1m) to EBITDA (220.2m): 0.60 < 3 |
| Current Ratio: 2.45 > 1.5 & < 3 |
| Outstanding Shares: last quarter (11.8m) vs 12m ago 0.08% < -2% |
| Gross Margin: 45.10% > 18% (prev 0.44%; Δ 4466 % > 0.5%) |
| Asset Turnover: 67.78% > 50% (prev 69.43%; Δ -1.64% > 0%) |
| Interest Coverage Ratio: 5.84 > 6 (EBITDA TTM 220.2m / Interest Expense TTM 29.2m) |
Altman Z'' 5.67
| A: 0.20 (Total Current Assets 520.0m - Total Current Liabilities 212.5m) / Total Assets 1.53b |
| B: 0.60 (Retained Earnings 925.6m / Total Assets 1.53b) |
| C: 0.11 (EBIT TTM 170.6m / Avg Total Assets 1.51b) |
| D: 1.55 (Book Value of Equity 885.7m / Total Liabilities 570.7m) |
| Altman-Z'' Score: 5.67 = AAA |
Beneish M -3.05
| DSRI: 1.09 (Receivables 182.2m/169.5m, Revenue 1.02b/1.03b) |
| GMI: 0.98 (GM 45.10% / 44.13%) |
| AQI: 0.96 (AQ_t 0.54 / AQ_t-1 0.57) |
| SGI: 0.99 (Revenue 1.02b / 1.03b) |
| TATA: -0.04 (NI 102.0m - CFO 162.5m) / TA 1.53b) |
| Beneish M-Score: -3.05 (Cap -4..+1) = AA |
What is the price of KAI shares?
Over the past week, the price has changed by +6.87%, over one month by +12.58%, over three months by +28.09% and over the past year by -6.69%.
Is KAI a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the KAI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 338.3 | -1.4% |
| Analysts Target Price | 338.3 | -1.4% |
| ValueRay Target Price | 388 | 13.1% |
KAI Fundamental Data Overview February 05, 2026
P/E Forward = 31.6456
P/S = 3.7706
P/B = 3.9809
P/EG = 3.2291
Revenue TTM = 1.02b USD
EBIT TTM = 170.6m USD
EBITDA TTM = 220.2m USD
Long Term Debt = 254.6m USD (from longTermDebt, last quarter)
Short Term Debt = 3.39m USD (from shortTermDebt, last quarter)
Debt = 258.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 131.1m USD (from netDebt column, last quarter)
Enterprise Value = 3.99b USD (3.86b + Debt 258.0m - CCE 126.9m)
Interest Coverage Ratio = 5.84 (Ebit TTM 170.6m / Interest Expense TTM 29.2m)
EV/FCF = 27.37x (Enterprise Value 3.99b / FCF TTM 145.9m)
FCF Yield = 3.65% (FCF TTM 145.9m / Enterprise Value 3.99b)
FCF Margin = 14.25% (FCF TTM 145.9m / Revenue TTM 1.02b)
Net Margin = 9.96% (Net Income TTM 102.0m / Revenue TTM 1.02b)
Gross Margin = 45.10% ((Revenue TTM 1.02b - Cost of Revenue TTM 562.2m) / Revenue TTM)
Gross Margin QoQ = 45.17% (prev 45.85%)
Tobins Q-Ratio = 2.61 (Enterprise Value 3.99b / Total Assets 1.53b)
Interest Expense / Debt = 6.75% (Interest Expense 17.4m / Debt 258.0m)
Taxrate = 29.50% (11.8m / 39.9m)
NOPAT = 120.3m (EBIT 170.6m * (1 - 29.50%))
Current Ratio = 2.45 (Total Current Assets 520.0m / Total Current Liabilities 212.5m)
Debt / Equity = 0.27 (Debt 258.0m / totalStockholderEquity, last quarter 949.8m)
Debt / EBITDA = 0.60 (Net Debt 131.1m / EBITDA 220.2m)
Debt / FCF = 0.90 (Net Debt 131.1m / FCF TTM 145.9m)
Total Stockholder Equity = 899.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.75% (Net Income 102.0m / Total Assets 1.53b)
RoE = 11.33% (Net Income TTM 102.0m / Total Stockholder Equity 899.7m)
RoCE = 14.78% (EBIT 170.6m / Capital Employed (Equity 899.7m + L.T.Debt 254.6m))
RoIC = 10.30% (NOPAT 120.3m / Invested Capital 1.17b)
WACC = 10.46% (E(3.86b)/V(4.12b) * Re(10.84%) + D(258.0m)/V(4.12b) * Rd(6.75%) * (1-Tc(0.30)))
Discount Rate = 10.84% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.13%
[DCF Debug] Terminal Value 71.28% ; FCFF base≈142.5m ; Y1≈156.3m ; Y5≈199.0m
Fair Price DCF = 185.1 (EV 2.31b - Net Debt 131.1m = Equity 2.18b / Shares 11.8m; r=10.46% [WACC]; 5y FCF grow 11.07% → 2.90% )
EPS Correlation: -38.78 | EPS CAGR: -46.69% | SUE: -4.0 | # QB: 0
Revenue Correlation: 84.02 | Revenue CAGR: 5.97% | SUE: 2.43 | # QB: 2
EPS next Quarter (2026-03-31): EPS=2.21 | Chg30d=-0.052 | Revisions Net=-1 | Analysts=4
EPS next Year (2026-12-31): EPS=10.27 | Chg30d=-0.113 | Revisions Net=-1 | Growth EPS=+11.8% | Growth Revenue=+10.6%